KR20020073576A - 트랜스막 세린 프로테아제를 암호화하는 핵산 분자,암호화된 단백질 및 이에 기초한 방법 - Google Patents

트랜스막 세린 프로테아제를 암호화하는 핵산 분자,암호화된 단백질 및 이에 기초한 방법 Download PDF

Info

Publication number
KR20020073576A
KR20020073576A KR1020027009973A KR20027009973A KR20020073576A KR 20020073576 A KR20020073576 A KR 20020073576A KR 1020027009973 A KR1020027009973 A KR 1020027009973A KR 20027009973 A KR20027009973 A KR 20027009973A KR 20020073576 A KR20020073576 A KR 20020073576A
Authority
KR
South Korea
Prior art keywords
mtsp
polypeptide
protein
cell
seq
Prior art date
Application number
KR1020027009973A
Other languages
English (en)
Korean (ko)
Inventor
에드윈 엘 메디슨
에드가 오 옹
지운-체른 여
Original Assignee
코르바스 인터내셔날, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/657,986 external-priority patent/US6797504B1/en
Application filed by 코르바스 인터내셔날, 인코포레이티드 filed Critical 코르바스 인터내셔날, 인코포레이티드
Publication of KR20020073576A publication Critical patent/KR20020073576A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Laminated Bodies (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
KR1020027009973A 2000-02-03 2001-02-02 트랜스막 세린 프로테아제를 암호화하는 핵산 분자,암호화된 단백질 및 이에 기초한 방법 KR20020073576A (ko)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US17998200P 2000-02-03 2000-02-03
US60/179,982 2000-02-03
US18354200P 2000-02-18 2000-02-18
US60/183,542 2000-02-18
US21312400P 2000-06-22 2000-06-22
US60/213,124 2000-06-22
US22097000P 2000-07-26 2000-07-26
US60/220,970 2000-07-26
US09/657,986 US6797504B1 (en) 2000-09-08 2000-09-08 Inhibitors of serine protease activity of matriptase or MTSP1
US09/657,986 2000-09-08
US23484000P 2000-09-22 2000-09-22
US60/234,840 2000-09-22
PCT/US2001/003471 WO2001057194A2 (en) 2000-02-03 2001-02-02 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon

Publications (1)

Publication Number Publication Date
KR20020073576A true KR20020073576A (ko) 2002-09-27

Family

ID=27558705

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027009973A KR20020073576A (ko) 2000-02-03 2001-02-02 트랜스막 세린 프로테아제를 암호화하는 핵산 분자,암호화된 단백질 및 이에 기초한 방법

Country Status (9)

Country Link
EP (1) EP1252300B1 (de)
JP (1) JP2003521920A (de)
KR (1) KR20020073576A (de)
AT (1) ATE496123T1 (de)
AU (1) AU2001233262A1 (de)
CA (1) CA2396774A1 (de)
DE (1) DE60143880D1 (de)
IL (1) IL150168A0 (de)
WO (1) WO2001057194A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101500670B1 (ko) * 2010-11-02 2015-03-10 인하대학교 산학협력단 암전이를 억제하는 항원 펩타이드, 이를 포함하는 암전이 백신, 암전이 억제 및 치료용 조성물 그리고 암전이 관련 표적물질 및 암전이 억제물질의 스크린 방법

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030039648A1 (en) 1998-09-16 2003-02-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
AU784746B2 (en) 1999-11-18 2006-06-08 Dendreon Corporation Nucleic acids encoding endotheliases, endotheliases and uses thereof
EP1280923A2 (de) 2000-04-28 2003-02-05 Millennium Pharmaceuticals, Inc. 14094, ein angehörige der menschlichen trypsin-familie, und dessen verwendungen
US6750034B1 (en) * 2000-06-30 2004-06-15 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human serine protease D-G
WO2002006455A2 (en) * 2000-07-19 2002-01-24 Bayer Aktiengesellschaft Regulation of human airway trypsin protease-like enzyme
US7157596B2 (en) 2000-09-08 2007-01-02 Dendreon Corporation Inhibitors of serine protease activity of matriptase or MTSP1
JP2004337001A (ja) * 2001-01-23 2004-12-02 Mochida Pharmaceut Co Ltd 新規なセリンプロテアーゼｍｐ４９３
US7700293B2 (en) 2001-08-02 2010-04-20 The Regents Of The University Of Michigan Expression profile of prostate cancer
US7332290B2 (en) 2001-08-02 2008-02-19 The Regents Of The University Of Michigan Dectection of AMACR cancer markers in urine
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
WO2003088898A2 (en) * 2002-04-17 2003-10-30 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
IL165244A0 (en) * 2002-05-31 2005-12-18 Schering Ag Control sequences of the human corin gene
EP1544304A4 (de) * 2002-07-31 2006-05-10 Astellas Pharma Inc Neue serinprotease
US6977170B2 (en) 2002-09-06 2005-12-20 Applera Corporation Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof
US7939304B2 (en) 2002-10-02 2011-05-10 Catalyst Biosciences, Inc. Mutant MT-SP1 proteases with altered substrate specificity or activity
DE10258051A1 (de) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Verwendung von an HAT bindenden Substanzen zur Diagnose und Behandlung des Plattenepithelkarzinoms der Lunge
US7019019B2 (en) 2002-12-23 2006-03-28 Dendreon Corporation Matriptase inhibitors and methods of use
US20060240432A1 (en) * 2003-01-24 2006-10-26 Eisai Co., Ltd. Lrp4/corin dopamine-producing neuron proliferation precursor cell marker
WO2004111225A1 (en) * 2003-06-11 2004-12-23 Schering Aktiengesellschaft Novel modified corin molecules having substitute activation sequences and uses thereof
CN101061217A (zh) 2004-02-27 2007-10-24 通用医疗公司 用于毛发生长的方法和组合物
JP5629423B2 (ja) 2004-04-12 2014-11-19 カタリスト バイオサイエンシーズ， インコーポレイテッド 野生型及び変異型ｍｔ−ｓｐ１による、ｖｅｇｆ及びｖｅｇｆ受容体の切断
DE102004023187A1 (de) * 2004-05-11 2005-12-01 Ganymed Pharmaceuticals Ag Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
AU2005264579B2 (en) 2004-07-22 2010-06-10 Eisai R&D Management Co., Ltd. Lrp4/Corin dopaminergic neuron progenitor cell markers
WO2007021003A1 (ja) 2005-08-18 2007-02-22 Eisai R & D Management Co., Ltd. ドーパミン産生ニューロン増殖前駆細胞マーカーＮａｔｏ３
WO2007047995A2 (en) 2005-10-21 2007-04-26 Catalyst Biosciences, Inc. Modified proteases that inhibit complement activation
JP2009540835A (ja) 2006-06-22 2009-11-26 ジェネンテック・インコーポレーテッド ヘプシンをターゲティングするための方法と組成物
NZ596729A (en) * 2006-06-22 2012-11-30 Genentech Inc Methods for identifying a candidate inhibitor substance that inhibits hepsin activation of pro-urokinase type plasminogen activator
KR20140072201A (ko) 2006-07-05 2014-06-12 카탈리스트 바이오사이언시즈, 인코포레이티드 프로테아제 스크리닝 방법 및 이에 의해 확인된 프로테아제
GB0614201D0 (en) * 2006-07-18 2006-08-23 Univ Cardiff Matriptase-2
DK2185933T3 (en) 2007-08-07 2015-10-26 Oxford Biotherapeutics Ltd MATRIPTASE PROTEIN AND APPLICATIONS THEREOF
EP2737057B1 (de) 2011-07-27 2018-10-24 Kyoto University Neue marker für dopaminerge neuronale vorläuferzellen
EP3074423A1 (de) 2013-11-25 2016-10-05 Oxford BioTherapeutics Ltd Antikörper gegen matriptase zur behandlung von krebs
WO2017162659A1 (en) 2016-03-24 2017-09-28 Bayer Pharma Aktiengesellschaft Intracellular hepsin as therapeutic target for the treatment of cancer with centrosome amplification
CA3136115A1 (en) * 2019-04-05 2020-10-08 Azitra Inc Methods and compositions for treating atopic dermatitis with recombinant microorganisms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952496A (en) 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
ES2176308T3 (es) 1993-10-28 2002-12-01 Houston Advanced Res Ct Dispositivo de microestructura porosa que permite un flujo.
JPH09149790A (ja) * 1995-09-29 1997-06-10 Suntory Ltd 新規セリンプロテアーゼ
US6203979B1 (en) * 1998-01-16 2001-03-20 Incyte Pharmaceuticals, Inc. Human protease molecules
US5972616A (en) 1998-02-20 1999-10-26 The Board Of Trustees Of The University Of Arkansas TADG-15: an extracellular serine protease overexpressed in breast and ovarian carcinomas
ES2312205T3 (es) * 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
JP2003506017A (ja) * 1999-07-12 2003-02-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング セリパンクリン

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101500670B1 (ko) * 2010-11-02 2015-03-10 인하대학교 산학협력단 암전이를 억제하는 항원 펩타이드, 이를 포함하는 암전이 백신, 암전이 억제 및 치료용 조성물 그리고 암전이 관련 표적물질 및 암전이 억제물질의 스크린 방법

Also Published As

Publication number Publication date
JP2003521920A (ja) 2003-07-22
ATE496123T1 (de) 2011-02-15
EP1252300B1 (de) 2011-01-19
EP1252300A2 (de) 2002-10-30
CA2396774A1 (en) 2001-08-09
DE60143880D1 (de) 2011-03-03
WO2001057194A3 (en) 2002-03-28
AU2001233262A1 (en) 2001-08-14
WO2001057194A2 (en) 2001-08-09
IL150168A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
US7888092B2 (en) Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
KR20020073576A (ko) 트랜스막 세린 프로테아제를 암호화하는 핵산 분자,암호화된 단백질 및 이에 기초한 방법
US7112430B2 (en) Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
US7105333B2 (en) Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
US7172892B2 (en) Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
US20030143219A1 (en) Nucleic acid molecules encoding a transmembrane serine protease 25, the encoded polypeptides and methods based thereon
US7125703B2 (en) Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
WO2003004681A2 (en) Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon
WO2003044179A2 (en) Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon
US20050112579A1 (en) Nucleic acid molecules encoding serine protease 16, the encoded polypeptides and methods based thereon
US7276364B1 (en) Nucleic acids encoding endotheliases, endotheliases and uses thereof
WO2003104394A2 (en) Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon
AU2002305595A1 (en) Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
AU2002252531A1 (en) Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
NZ529387A (en) An endotheliase 1 protease or protease domain thereof, nucleic acids encoding therefor, uses thereof and recombinant non-human animals comprising the protein
ZA200203366B (en) Nucleic acids encoding endotheliases, endotheliases and uses thereof.

Legal Events

Date Code Title Description
N231 Notification of change of applicant
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid